Georges Gemayel, Director at NPS PHARMACEUTICALS INC (NPSP), sold 6,188 shares at $37.70 ($233K) on 2014-02-13, disclosed to the SEC on 2014-02-14.
Scheduled sale ($233k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SUPN | SELL | 2024-11-08 | $1.0M | — | Filing → |
| SUPN | SELL | 2024-09-17 | $557K | — | Filing → |
| MNTA | SELL | 2020-08-07 | $330K | — | Filing → |